等待开盘 11-29 09:30:00 美东时间
+0.010
+0.16%
鉴于乐观的前景,Raymond James将RXT评级提升为“跑赢大盘”;专注于癫痫病药物研发公司Marinus制药隔夜涨20%;软件开发公司Endava第四季度收益超出预期>>
09-20 18:15
GAAP Operating Expense: The Company now expects GAAP operating expenses, inclusive of G&A and R&D, to be in the range of $160 to $165 million, of which the Company expects stock-based
08-10 19:08
Marinus Pharma (NASDAQ:MRNS) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.72) by 15.28 percent. This is a 42.45 percent increase over losses of $(1.06) per share from
08-10 19:03
Marinus Pharma (NASDAQ:MRNS) is set to give its latest quarterly earnings repor...
08-10 00:01
8月9日报道,根据美国证券交易委员会(SEC)8月8日披露的文件,$Marinus Pharmaceuticals(MRNS.US)$首席医疗官Hulihan...
08-09 09:43
When you buy shares in a company, there is always a risk that the price drops t...
08-02 09:55
This whale alert can help traders discover the next big trading opportunities. ...
06-30 01:39
Analysts have provided the following ratings for Marinus Pharma (NASDAQ:MRNS) w...
06-24 03:00
Within the last quarter, Marinus Pharma (NASDAQ:MRNS) has observed the followin...
05-30 22:02